Could one pill per month prevent HIV? The IMPOWER 22 study will find out.
Could one pill per month prevent HIV? The IMPOWER 22 study will find out.
This clinical research study is testing the safety and effectiveness of an investigational monthly PrEP pill (called islatravir) that may protect against HIV-1.
The study is open, but not currently enrolling (see: Merck Announces Clinical Holds on Studies Evaluating Islatravir for the Treatment and Prevention of HIV-1 Infection).
“A monthly pill would empower me to lead an HIV-free life—imagine, only 12 pills in a year; Unbelievable!”
— Dr. Brenda Gati Mirembe, Senior Investigator, MH-JHU Care LTD, Uganda